GoAI
Get started
NeuroPace, Inc. logo

NeuroPace, Inc.

NPCE

NASDAQHealthcareMedical - Devices

Open in GoAI

Previous close

$14.03

+$0.01 · +0.07%

Aug 21, 4:00 PM ET

NPCE company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

75

Undervalued

Momentum

50

Neutral

Sentiment

59

Mixed

Risk resilience

49

Elevated Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Industry
Medical - Devices
Sector
Healthcare
Headquarters
US

Market position

Day range

Current $14.03

52-week range

Current $14.03

Open
$14.06
Previous close
$14.02
Volume
115.98K
Market cap
478.34M USD
50-day average
$15.3298
-8.48% below average
200-day average
$15.3872
-8.82% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

P/E (TTM)
-24.54×
P/B (TTM)
40.27×
P/S (TTM)
4.84×
Dividend yield
0.00%

Profitability & efficiency

Gross margin
79.63%
Operating margin
-15.26%
Net margin
-19.34%

Financial health

Debt / equity
5.88×
Altman Z-score
-3.38
Piotroski F-score
3 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends95%23%-49%-121%Gross margin, FY2021: 74.00%Gross margin, FY2022: 71.38%Gross margin, FY2023: 73.56%Gross margin, FY2024: 73.94%Gross margin, FY2025: 77.23%Operating margin, FY2021: -52.54%Operating margin, FY2022: -89.62%Operating margin, FY2023: -41.54%Operating margin, FY2024: -27.12%Operating margin, FY2025: -16.34%Net margin, FY2021: -79.85%Net margin, FY2022: -103.43%Net margin, FY2023: -50.38%Net margin, FY2024: -33.97%Net margin, FY2025: -21.47%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 74.00%. Gross margin FY2022 71.38%. Gross margin FY2023 73.56%. Gross margin FY2024 73.94%. Gross margin FY2025 77.23%. Operating margin FY2021 -52.54%. Operating margin FY2022 -89.62%. Operating margin FY2023 -41.54%. Operating margin FY2024 -27.12%. Operating margin FY2025 -16.34%. Net margin FY2021 -79.85%. Net margin FY2022 -103.43%. Net margin FY2023 -50.38%. Net margin FY2024 -33.97%. Net margin FY2025 -21.47%.

Income trends

Revenue

99.99M USD+25.13%

Operating income

−16.34M USD+24.61%

Net income

−21.47M USD+20.91%
Income trends across reported periods114.69M USD55.87M USD−2.96M USD−61.79M USDRevenue, FY2021: 45.18M USDRevenue, FY2022: 45.52M USDRevenue, FY2023: 65.42M USDRevenue, FY2024: 79.91M USDRevenue, FY2025: 99.99M USDOperating income, FY2021: −23.74M USDOperating income, FY2022: −40.79M USDOperating income, FY2023: −27.17M USDOperating income, FY2024: −21.67M USDOperating income, FY2025: −16.34M USDNet income, FY2021: −36.08M USDNet income, FY2022: −47.08M USDNet income, FY2023: −32.96M USDNet income, FY2024: −27.14M USDNet income, FY2025: −21.47M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 45.18M USD. Revenue FY2022 45.52M USD. Revenue FY2023 65.42M USD. Revenue FY2024 79.91M USD. Revenue FY2025 99.99M USD. Operating income FY2021 −23.74M USD. Operating income FY2022 −40.79M USD. Operating income FY2023 −27.17M USD. Operating income FY2024 −21.67M USD. Operating income FY2025 −16.34M USD. Net income FY2021 −36.08M USD. Net income FY2022 −47.08M USD. Net income FY2023 −32.96M USD. Net income FY2024 −27.14M USD. Net income FY2025 −21.47M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue99.99M USD79.91M USD65.42M USD45.52M USD45.18M USD
Cost of goods sold22.77M USD20.82M USD17.3M USD13.03M USD11.75M USD
Gross profit77.22M USD59.09M USD48.12M USD32.49M USD33.44M USD
Research and development27.89M USD23.65M USD20.78M USD21.95M USD18.21M USD
Selling, general, and administrative65.67M USD57.1M USD54.52M USD51.34M USD38.96M USD
Operating expenses93.56M USD80.76M USD75.3M USD73.29M USD57.17M USD
Interest income2.82M USD3.02M USD3.05M USD1.58M USD448K USD
Interest expense7.46M USD8.8M USD8.52M USD7.53M USD7.41M USD
Depreciation and amortization1.95M USD1.77M USD1.61M USD2.99M USD296K USD
Operating income−16.34M USD−21.67M USD−27.17M USD−40.79M USD−23.74M USD
Net income−21.47M USD−27.14M USD−32.96M USD−47.08M USD−36.08M USD

Company facts updated Aug 24, 2026.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$21.00

49.68% upside
Past 12 months12-month forecastHigh $22.00Average $21.00Low $20.00

Rating distribution

10 ratings
Strong buy00%
Buy990%
Hold110%
Sell00%
Strong sell00%

NPCE peers

Amgen Inc. logo

AMGN

Amgen Inc.

$439.33

+1.29%

Gilead Sciences, Inc. logo

GILD

Gilead Sciences, Inc.

$146.12

+1.87%

Vertex Pharmaceuticals Incorporated logo

VRTX

Vertex Pharmaceuticals Incorporated

$548.05

+1.44%

Intuitive Surgical, Inc. logo

ISRG

Intuitive Surgical, Inc.

$378.81

+1.16%

Sanofi logo

SNY

Sanofi

$45.85

+1.55%

Regeneron Pharmaceuticals, Inc. logo

REGN

Regeneron Pharmaceuticals, Inc.

$834.04

+0.90%

ETFs holding NPCE

Funds reporting this stock among their holdings, ordered by reported position size.

Vanguard Morningstar Total Stock Market ETF logoVanguard Morningstar Total Stock Market ETFVTI
Market value
11.71M
Weight
0.00%
AUM
2.3T USD
Expense ratio
0.03%
Price / 1D
$378.24+0.44%
iShares Russell 2000 ETF logoiShares Russell 2000 ETFIWM
Market value
9.51M
Weight
0.01%
AUM
81.62B USD
Expense ratio
0.19%
Price / 1D
$299.96+0.77%
Vanguard Extended Market ETF logoVanguard Extended Market ETFVXF
Market value
3.75M
Weight
0.00%
AUM
93.7B USD
Expense ratio
0.05%
Price / 1D
$245.53+0.82%
iShares Russell 2000 Growth ETF logoiShares Russell 2000 Growth ETFIWO
Market value
3.49M
Weight
0.02%
AUM
15.16B USD
Expense ratio
0.24%
Price / 1D
$387.37+1.24%
Vanguard Russell 2000 ETF logoVanguard Russell 2000 ETFVTWO
Market value
1.92M
Weight
0.01%
AUM
17.4B USD
Expense ratio
0.06%
Price / 1D
$121.25+0.74%
iShares Micro-Cap ETF logoiShares Micro-Cap ETFIWC
Market value
1.28M
Weight
0.08%
AUM
1.53B USD
Expense ratio
0.60%
Price / 1D
$198.39+1.10%
State Street SPDR S&P Health Care Equipment ETF logoState Street SPDR S&P Health Care Equipment ETFXHE
Market value
582.04K
Weight
0.33%
AUM
176.38M USD
Expense ratio
0.35%
Price / 1D
$96.68+1.37%
Vanguard Russell 2000 Growth ETF logoVanguard Russell 2000 Growth ETFVTWG
Market value
367.76K
Weight
0.02%
AUM
1.7B USD
Expense ratio
0.06%
Price / 1D
$282.73+1.21%

Continue in GoAI

Research NPCE

research.disclaimer